Depletion of FGL2 inhibited colorectal carcinoma progression and enhanced epithelial‐to‐mesenchymal transition in vitro and in vivo,29 and deficiency of host FGL2 was associated with reduced growth of lung cancer.30 The gene discussed is FGL2; the disease is lung carcinoma.